Abstract

Cell penetrating peptides (CPPs) are being increasingly used as efficient vectors for intracellular delivery of biologically active agents, such as therapeutic antisense oligonucleotides (ASOs). Unfortunately, ASOs have poor cell membrane permeability. The conjugation of ASOs to CPPs have been shown to significantly improve their cellular permeability and therapeutic efficacy. CPPs are often covalently conjugated to ASOs through a variety of chemical linkages. Most of the reported approaches for ligation of CPPs to ASOs relies on methodologies that forms non-native bond due to incompatibility with in-solution phase conjugation. These approaches have low efficiency and poor yields. Therefore, in this study, we have exploited native chemical ligation (NCL) as an efficient strategy for synthesizing CPP-ASO conjugates. A previously characterized CPP [ApoE(133–150)] was used to conjugate to a peptide nucleic acid (PNA) sequence targeting human survival motor neuron-2 (SMN2) mRNA which has been approved by the FDA for the treatment of spinal muscular atrophy. The synthesis of ApoE(133–150)-PNA conjugate using chemo-selective NCL was highly efficient and the conjugate was obtained in high yield. Toward synthesizing trifunctional CPP-ASO conjugates, we subsequently conjugated different functional moieties including a phosphorodiamidate morpholino oligonucleotide (PMO), an additional functional peptide or a fluorescent dye (Cy5) to the thiol that was generated after NCL. The in vitro analysis of the bifunctional CPP-PNA and trifunctional CPP-(PMO)-PNA, CPP-(peptide)-PNA and CPP-(Cy5)-PNA showed that all conjugates are cell-permeable and biologically active. Here we demonstrated chemo-selective NCL as a highly efficient and superior conjugation strategy to previously published methods for facile solution-phase synthesis of bi-/trifunctional CPP-ASO conjugates.

Highlights

  • Cell penetrating peptides (CPPs) are relatively short cationic, amphipathic peptides (Kurrikoff et al, 2020) and are being widely used for intracellular drug delivery for a wide range of cell-impermeable cargoes, such as therapeutic antisense oligonucleotides (ASOs)

  • The CPP [ApoE (133–150)] was synthesized as a C-terminal hydrazide and a miniPEG spacer was placed between the C-terminal glycyl hydrazide and the peptide sequence

  • We have demonstrated for the first time the use of hydrazide-based native chemical ligation (NCL) as an efficient and site-specific approach for the preparation of trifunctional peptide-ASO conjugates

Read more

Summary

Introduction

CPPs are relatively short cationic, amphipathic peptides (Kurrikoff et al, 2020) and are being widely used for intracellular drug delivery for a wide range of cell-impermeable cargoes, such as therapeutic antisense oligonucleotides (ASOs). There is limited evidence of ASO-associated toxicity but CPPs can be toxic even at very low doses. A key consideration when designing CPP-ASO conjugates is their efficient synthesis. They are often assembled separately via solidphase synthesis and conjugated using a variety of chemical linkages, such as disulfide (Turner et al, 2005; Saleh et al, 2010), amide (Bruick et al, 1996; Betts et al, 2012; Shabanpoor and Gait, 2013), thioether (Patil et al, 2019), triazole, oxime, hydrazone, and thiazole bonds (Lu et al, 2010; Nikan et al, 2020). We have previously found that the formation of thiazoles and in particular triazoles (Patil et al, 2019) are slow, and reduce the solubility of the CPP-ASO conjugate

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call